$64.58

0.58 (0.91%)

11/21/2008 4:01 PM

Barr Pharmaceuticals, Inc. (BRL)

CAPS Rating:

A specialty pharmaceutical Company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BRL

Add Stock to Watchlist

What the Community Thinks

Total Members

767 Outperforms

47 Underperforms

All-Stars

223 Outperforms

4 Underperforms

Wall Street

8 Outperforms

2 Underperforms

Members bullish on BRL are also bullish on:

Members bearish on BRL are also bearish on:

Ticker Tags

Mid Cap (425), S&P 500 (469), Pharmaceuticals (148)
Suggest a tag

Barr Pharmaceuticals, Inc. At A Glance

Current Price:	$64.58
Last Trade Time:	11/21/2008 4:01 PM
Open:	$64.22
Previous Close:	$64.00
Daily Range:	$62.99 - $64.72
52-Week Range:	$37.40 - $68.35
Volume:	2,791,684
Market Cap:	$7.00B
P/E Ratio:	45.39
Compare Our Special Broker Offers!

Stock Trends

BRL VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for BRL

Sanofi-Aventis settles patent infringement cases
11/19/2008 8:56:00 AM - AP
Teva, Barr settle patent dispute with Sanofi
11/19/2008 7:26:00 AM - AP
Sector Snap: Generic drug cos. show strong profits
11/6/2008 1:54:00 PM - AP
Teva earnings rose 20 percent in third quarter
11/6/2008 12:48:00 PM - AP

More Headlines...

Top Bull Pitch

Recs

1 Barr Pharmaceuticals, Inc. (BRL)

Avatar petejose (51.04) Submitted: 5/08/08 11:58 AM

The basis for owning this (I have real money at a loss right now) is that the industry is in for long, appreciating demand with the population aging and the economy prepared for inflation. Recession money is decently sheltered in basic necessities, such as groceries, utilities, and pharmaceuticals....More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3 Barr Pharmaceuticals, Inc. (BRL)

Avatar ffishernc (30.38) Submitted: 3/27/07 9:38 PM

Although a well managed company, the major manufacturers are beginning to market their own "generic" versions. The generics are sold ONLY on price. I am afraid that the big boys have enough $ to put the competition on the ropes.

Replies: 1 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 127 : 1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs 0 (BRL) OracleApp (86.60) Submitted: 11/01/08 8:16 AM : Start Price: $63.84 BRL Score: 22.87 buy Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (BRL) alvojiggy1 (80.03) Submitted: 10/22/08 9:45 PM : Start Price: $61.89 BRL Score: -20.53 going into the crapper. high debt bad forward earnings. I love the stock market. People spend a lot of energy trying to get a company to work...so sad. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (BRL) PDTBiotech (84.59) Submitted: 10/01/08 12:25 PM : Start Price: $65.96 BRL Score: 32.25 Spec on buyout deal with TEVA: Some algebra on the deal: ($39.90) + (0.6272 * current price of TEVA stock) = price/share for buyout If you think the buyout's going through, and the calculated price/share is greater than BRL's current price (buyout currently $69.10 vs. BRL now at $65.67), this might not be a bad place to put some defensive money for the rest of the year. TEVA and BRL expect it to go through by the end of the year, and the way it's structured any bump in TEVA will jack up the acquisition price with a little hedge due to the gap between deal value and current BRL price. I like TEVA a lot, will probably pick it up for a LTBH once the final announcement on the deal is made whether it goes through or not. Report this Post Replies: 1 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (BRL) horseflab (62.89) Submitted: 9/10/08 3:04 PM : Start Price: $66.77 BRL Score: 35.77 Very strong earnings and growth rate YTD Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (BRL) trm3 (< 20) Submitted: 9/09/08 2:46 PM : Start Price: $66.90 BRL Score: 35.56 http://www.tradingmarkets.com/.site/quotescharts/?qm_symbol=BRL Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 127 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 10 of 10

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackCowenandCo	78.45	05/13/08		NS	$40.98	+57.59%	-45.99%	+103.58
	TrackBofASec	95.85	12/18/07		NS	$52.45	+23.13%	-48.09%	+71.22
	TrackEdwardOwens	99.48	09/30/07		NS	$56.91	+13.48%	-50.30%	+63.78
	TrackBernstein	89.78	05/10/07		NS	$53.58	+20.53%	-49.69%	+70.22
	TrackUBS	85.75	03/23/07		NS	$48.96	+31.90%	-47.08%	+78.99
	TrackLehmanBros	< 20	01/31/07		NS	$53.60	+20.49%	-46.83%	+67.32
	TrackBarronsRoun	79.76	01/22/07		1Y	$52.31	+23.46%	-46.74%	+70.19
	TrackMatrix	90.83	10/24/06		NS	$52.50	+23.01%	-44.76%	+67.77
	TrackJimCramer	85.65	08/22/06		3W	$58.28	+10.81%	-41.72%	-52.53

Results 1 - 10 of 10

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.